Moreover, probiotic-derived metabolites such as indole derivatives and polyamines modulate inflammatory signaling by inhibiting NF-κB and reducing the production of pro-inflammatory cytokines like IL-6 and IL-1β, which are often elevated in cancer-associated inflammation [46]. Here, NFKB1 is linked to cancer.